$LADX News
Last published 1y ago
- 1y agoLADXLadRx Corporation, Inc. to Present at the Virtual Life Science Investor Forum March 13thGlobeNewswireLOS ANGELES, March 12, 2025 (GLOBE NEWSWIRE) -- LadRx Corporation (OTCQB:LADX) ("LadRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, is
- 1y agoLADXLadRx Planning NDA Submission under 505(b)(2) for Aldoxorubicin and Other UpdatesBusiness WireCompany expects package will not require additional human clinical studies, potentially accelerating path to market LadRx Corporation (OTCQB:LADX) ("LadRx" or the "Company"), a biopharmaceutical innovator focused on
- 2y agoLADXXOMALadRx and ImmunityBio Mutually Agree to Terminate Aldoxorubicin LicenseBusiness WireAldoxorubicin Returns to LadRx LadRx Corporation (OTCQB:LADX) ("LadRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, is pleased to announce
- 2y agoLADXXOMAZVRALadRx Issues 2024 Update to ShareholdersBusiness WireFDA Acceptance of Arimoclomol Triggers $1 Million Payment LadRx Corporation (OTCQB:LADX) ("LadRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer
- 3y agoLADXXOMALadRx Completes Non-Dilutive Financing Transaction for up to $11 Million with XOMA CorporationBusiness WireXOMA acquires future milestone economics and royalties associated with arimoclomol and aldoxorubicin, allowing LadRx to focus on core LADR assets LadRx Corporation (OTCQB:LADX) ("LadRx" or the
- 3y agoLADXLadRx Announces Reverse Stock Split Effective as of May 17, 2023Business WireLadRx Corporation (OTCQB:LADX) ("LadRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today announced that its previously announced reverse
- 3y agoLADXLadRx Announces Reverse Stock SplitBusiness WireLadRx Corporation (OTCQB:LADX) ("LadRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today announced that it intends to effect a reverse stock
- 3y agoLADXLadRx Highlights Patent Issued for Its LADR TechnologyBusiness WireLadRx Corporation (OTCQB:LADX) ("LadRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today highlighted that it has been issued a patent from
- 3y agoLADXLadRx Announces Review of Strategic Alternatives and Provides Corporate UpdatesBusiness WireLadRx Corporation (OTCQB:LADX) ("LadRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, announced today that it has initiated a process to explore
- 3y agoIBRXLADXLadRx Corporation Issues Corporate Update for 3Q22Business WireLadRx Corporation (OTCQB:LADX) ("LadRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today issued the below update to
- 4y agoCYTRLADXLadRx Corporation Announces OTCQB Ticker Change to LADXBusiness WireLadRx Corporation (OTCQB:LADX) ("LadRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today announced it is changing its OTCQB ticker symbol from CYTR to LADX effective Thursday,